SCHEMBL6216611

SCHEMBL6216611

Cc1c(OCc2ccccc2)c2ccccn2c1C(=O)c1ccc(C(=O)O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.50
SRD5A2 P31213 2/20 0.50
NR4A1 P22736 1/20 0.47
NR4A2 P43354 1/20 0.47
NR4A3 Q92570 1/20 0.47
RXRA P19793 2/20 0.45
RXRB P28702 1/20 0.45
RXRG P48443 1/20 0.45
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
ALDH1A1 P00352 4/20 0.44
GAA P10253 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HPGD P15428 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MAPT P10636 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3594590 0.90 LMNA (0.50) HTTMEN1KMT2AALDH1A1GAA
SCHEMBL146411 0.84 RXRA (0.46) HTTRXRARXRBRXRGMEN1
SCHEMBL145768 0.84 HTT (0.55) HTTMEN1KMT2AALDH1A1GAA
SCHEMBL6220010 0.83 HTT (0.54) HTTMEN1KMT2AALDH1A1GAA
SCHEMBL142912 0.81 HTT (0.58) HTTMEN1KMT2AALDH1A1GAA
SCHEMBL321478 0.81 LMNA (0.46) HTTMEN1KMT2AALDH1A1GAA
SCHEMBL3587683 0.80 NPC1 (0.43) KMT2AALDH1A1HPGDMAPTLMNA
SCHEMBL6217512 0.77 HTT (0.59) HTTSRD5A2MEN1KMT2AALDH1A1
SCHEMBL142911 0.77 HTT (0.59) HTTMEN1KMT2AALDH1A1GAA
SCHEMBL1573315 0.76 SRD5A2 (0.37) HTTSRD5A2NR4A2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1495023-B1 NOVEL 1,2,3-SUBSTITUTED INDOLIZINE DERIVATIVES, INHIBITORS OF FGFS, METHOD FOR MAKING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SANOFI AVENTIS (FR) 2005-09-07 EP disclosed
EP-1495023-A1 NOVEL 1,2,3-SUBSTITUTED INDOLIZINE DERIVATIVES, INHIBITORS OF FGFS, METHOD FOR MAKING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Sanofi-Aventis (FR) 2005-01-12 EP disclosed
WO-2003084956-A1 NOVEL 1,2,3-SUBSTITUTED INDOLIZINE DERIVATIVES, INHIBITORS OF FGFS, METHOD FOR MAKING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SANOFI-AVENTIS (FR) 2003-10-16 WO disclosed